Search Results - Nagy, P.I.

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Monte Carlo Simulations of the Solution Structure of Simple Alcohols in Water−Acetonitrile Mixtures

    Monte Carlo Simulations of the Solution Structure of Simple Alcohols in Water−Acetonitrile Mixtures by Nagy, Peter I, Erhardt, Paul W

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Mutant M 1 muscarinic receptors with increased agonist affinity and G protein coupling

    Mutant M 1 muscarinic receptors with increased agonist affinity and G protein coupling by Messer, W.S., Huang, X.-P., Nagy, P.I., Williams, F.E., Peseckis, S.M.

    Published in Life sciences (1973)
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Mutant M1 muscarinic receptors with increased agonist affinity and G protein coupling

    Mutant M1 muscarinic receptors with increased agonist affinity and G protein coupling by Messer, W.S., Huang, X.-P., Nagy, P.I., Williams, F.E., Peseckis, S.M.

    Published in Life sciences (1973)
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Molecular studies of agonist interactions with wild-type, T234A, and N507A m3 receptors

    Molecular studies of agonist interactions with wild-type, T234A, and N507A m3 receptors by Huang, X.-P., Edgar, M.A.N., Freed, J., Peseckis, S., Nagy, P.I., Ojo, B., Zhang, H., Messer, W.S.

    Published in Life sciences (1973)
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Development of 5-(3-alkenyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine derivatives as selective muscarinic agonists for the treatment of Alzheimer's disease

    Development of 5-(3-alkenyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine derivatives as selective muscarinic agonists for the treatment of Alzheimer's disease by Zhang, H., Ojo, B., Huang, X.-P., Edgar, M.A.N., El-Assadi, A.A., Baril, D., Lynch, K., Wahidy, S., Nagy, P.I., Messer, W.S.

    Published in Life sciences (1973)
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Fibrinogen function is impaired in whole blood from patients with cyanotic congenital heart disease

    Fibrinogen function is impaired in whole blood from patients with cyanotic congenital heart disease by Jensen, A.S, Johansson, P.I, Bochsen, L, Idorn, L, Sørensen, K.E, Thilén, U, Nagy, E, Furenäs, E, Søndergaard, L

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    The haematocrit – an important factor causing impaired haemostasis in patients with cyanotic congenital heart disease

    The haematocrit – an important factor causing impaired haemostasis in patients with cyanotic congenital heart disease by Jensen, A.S, Johansson, P.I, Idorn, L, Sørensen, K.E, Thilén, U, Nagy, E, Furenäs, E, Søndergaard, L

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Response letter to: “Hypocoagulable” thromboelastography profiles in patients with cyanotic congenital heart disease: Facts or technical artifacts?

    Response letter to: “Hypocoagulable” thromboelastography profiles in patients with cyanotic congenital heart disease: Facts or technical artifacts? by Jensen, A.S, Johansson, P.I, Bochsen, L, Idorn, L, Sørensen, K.E, Thilén, U, Nagy, E, Furenäs, E, Søndergaard, L

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: